Skip to content
POSTDOC opening

Postdoc – In vitro models and mechanistic investigation into Astroblastoma

Prinses Máxima Centrum · Netherlands

Back to openings

About this position

We are seeking an enthusiastic and ambitious postdoctoral researcher to join the Artegiani & Hendriks group at the Princess Máxima Center for Pediatric Oncology. You will lead the development and study of relevant human in vitro models of astroblastoma, a newly recognized pediatric brain tumor type. Working in a highly collaborative environment together with the Kool group in the Máxima, you will uncover the developmental origins, molecular mechanisms and sex-specific biology of astroblastoma, providing a roadmap also for future therapeutic strategies.

The research project

Astroblastoma is a rare pediatric brain tumor for which no standard treatment currently exists. Recent work from the Kool group identified three molecular subtypes characterized by distinct fusion genes, anatomical locations, clinical behavior and a remarkable female predominance in one subtype (PMID: 41429568). However, the mechanisms underlying tumor initiation, cellular origin and sex bias remain unknown.

As a postdoctoral researcher working on this collaborative project, you will generate novel in vitro human models of astroblastoma, and use these for functional experiments, to understand the developmental cell(s)-of-origin and uncover mechanisms underlying the striking sex differences observed in these tumors. These models will also be extensively molecularly characterized in collaboration with the postdoctoral researcher in the Kool group, guiding functional validation studies.

The project is embedded within a large international network on rare pediatric brain tumors and includes collaborations with leading experts in pediatric neuro-oncology, developmental neuroscience, genomics and bioinformatics across Europe. You will work closely with clinicians, computational biologists, molecular pathologists and organoid researchers at the Princess Máxima Center.

Your profile

We are looking for a highly motivated and independent scientist who is excited to address fundamental questions in pediatric brain tumor biology. Together with the second postdoctoral researcher you will spearhead this project.

You should have:

  • PhD in molecular, stem cell, or cancer biology related disciplines. Other field will not be considered.
  • Demonstrated wet lab experience, possibly in advanced cell culture models, such as organoids, and related techniques.
  • Previous experience with pediatric (brain) tumors, developmental neuroscience, or cancer epigenomics is advantageous.
  • A competitive publication record (including first authorship or submitted papers in internationally recognized journals)
  • A degree of bioinformatic skills is a pro.
  • A strong intrinsic motivation for scientific research.
  • Excellent analytical and problem-solving skills with the ability to independently develop biological hypotheses from complex datasets.
  • Strong organizational skills, attention to detail and excellent data management practices.
  • Excellent written and verbal communication skills in English.
  • The ability to work independently while thriving in a multidisciplinary and international research environment.

Members only · Free to join

Sign in to see the full opening

Get the entry requirements, funding, the supervisor's contact and a link to the original advert.

  • Requirements
  • How to apply
  • Contact details

Free forever No credit card 30-second sign-up

Similar openings

Funding not stated 9 Nov 2026

CDD Post-doc in yeast evolutionary genomics (M/F)

CNRS · Institut de Recherche sur le Cancer et le Vieillissement, Nice

  • NICE, France
  • Biological sciences

The post-doc will contribute to the ANR project EDGES (Evolving genomes beyond species boundaries), which investigates how genomes acquire, assimilate and evolve large amounts of foreign and extra-self DNA (fsDNA) in the budding yeast Saccharomyces cerevisiae. The post-doc will lead work on the natural uptake of environmental DNA, the reprogramming of mating to enable interspecies hybridisation, and the adaptive pote

Funding not stated 9 Nov 2026

Identifying druggable targets for differentiation therapy in glioblastoma - MFAG 2025 Rif. 32663 – CUP E63C25001800007

Università di Trento

  • Italy
  • Biological sciences

Glioblastoma (GBM) is the most common and aggressive central nervous system malignancy in adults. This research project aims to identify novel druggable molecular targets to advance differentiation therapy strategies for glioblastoma (GBM). By inducing terminal differentiation of glioma stem cells (GSCs) and converting stem-like cells into non-stem states sensitive to conventional treatments, this project aims to red

Funding not stated 9 Nov 2026

Postdoc MetNH3Energy

Delft University of Technology (TU Delft)

  • Delft, Netherlands
  • Engineering » Process engineering

Work at the intersection of hydrogen, ammonia, and sustainability. Join the MetNH3Energy project and help identify low-carbon solutions that can power Europe's energy trans Job description The European Union (EU), through initiatives such as REPowerEU, REFuelEU, and FuelEU Maritime, is driving the transition toward lower greenhouse gas emissions. Green hydrogen is expected to play a key role, with part of the deman

Funding not stated 9 Nov 2026

Postdoc MetNH3Energy

Delft University of Technology (TU Delft)

  • Delft, Netherlands

Work at the intersection of hydrogen, ammonia, and sustainability. Join the MetNH3Energy project and help identify low-carbon solutions that can power Europe's energy trans Job description The European Union (EU), through initiatives such as REPowerEU, REFuelEU, and FuelEU Maritime, is driving the transition toward lower greenhouse gas emissions. Green hydrogen is expected to play a key role, with part of the demand